Video

Capping margins on 137 cancer drugs cut prices by ~₹6,000, but costly patented drugs stayed high.

The government’s decision to limit the extra profit added by pharmacies and distributors to 137 cancer drugs has led to an average price reduction of nearly ₹6,000 per drug. However, the cuts were not equal.

Story details

Producer
Spot On
Last updated